Prothena Corporation PLCNASDAQ:PRTA
- LAST PRICE56.5500
- TODAY'S CHANGE (%)1.5900 (2.8930%)
- Bid / Lots52.8800/ 1
- Ask / Lots56.5000/ 1
- Open / Previous Close55.2800 / 54.9600
- Day Range
- 52 Week Range
- Volume434,634
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PRTA |
|---|---|---|
| 09:32 ET | 3934 | 55.345 |
| 09:33 ET | 100 | 55.85 |
| 09:37 ET | 100 | 55.6684 |
| 09:42 ET | 100 | 55.85 |
| 09:51 ET | 100 | 56.22 |
| 09:53 ET | 100 | 56.11 |
| 09:55 ET | 200 | 56.11 |
| 09:57 ET | 100 | 56.245 |
| 10:00 ET | 100 | 56.24 |
| 10:02 ET | 100 | 56.39 |
| 10:04 ET | 1414 | 55.885 |
| 10:06 ET | 1200 | 55.58 |
| 10:08 ET | 16199 | 55.53 |
| 10:09 ET | 400 | 55.64 |
| 10:11 ET | 123 | 55.65 |
| 10:13 ET | 800 | 55.935 |
| 10:15 ET | 10974 | 55.85 |
| 10:18 ET | 5995 | 55.7 |
| 10:20 ET | 2771 | 55.8 |
| 10:22 ET | 1763 | 55.735 |
| 10:24 ET | 300 | 55.705 |
| 10:26 ET | 100 | 55.85 |
| 10:27 ET | 100 | 55.835 |
| 10:29 ET | 200 | 55.9 |
| 10:33 ET | 400 | 55.895 |
| 10:36 ET | 100 | 55.9 |
| 10:38 ET | 200 | 56.01 |
| 10:40 ET | 1100 | 55.81 |
| 10:42 ET | 100 | 55.87 |
| 10:44 ET | 300 | 56.02 |
| 10:45 ET | 4307 | 55.78 |
| 10:47 ET | 100 | 55.705 |
| 10:51 ET | 100 | 55.745 |
| 10:54 ET | 900 | 55.71 |
| 10:56 ET | 200 | 55.74 |
| 10:58 ET | 800 | 55.71 |
| 11:02 ET | 300 | 55.82 |
| 11:03 ET | 200 | 55.9 |
| 11:05 ET | 200 | 55.89 |
| 11:07 ET | 700 | 55.895 |
| 11:09 ET | 200 | 55.96 |
| 11:12 ET | 14839 | 56.03 |
| 11:14 ET | 300 | 56.13 |
| 11:16 ET | 273 | 56.13 |
| 11:18 ET | 1409 | 56.16 |
| 11:20 ET | 600 | 56.085 |
| 11:21 ET | 500 | 56.1 |
| 11:23 ET | 200 | 56.11 |
| 11:25 ET | 300 | 56.09 |
| 11:27 ET | 100 | 56.09 |
| 11:30 ET | 300 | 56.16 |
| 11:32 ET | 2600 | 55.96 |
| 11:34 ET | 603 | 55.925 |
| 11:36 ET | 1297 | 56.02 |
| 11:38 ET | 1100 | 55.975 |
| 11:39 ET | 100 | 55.83 |
| 11:41 ET | 631 | 55.957 |
| 11:43 ET | 600 | 56 |
| 11:45 ET | 1100 | 56 |
| 11:48 ET | 900 | 55.975 |
| 11:50 ET | 824 | 55.89 |
| 11:52 ET | 100 | 55.88 |
| 11:54 ET | 108 | 55.82 |
| 11:56 ET | 4854 | 56.1 |
| 11:57 ET | 200 | 56.08 |
| 11:59 ET | 1100 | 56.04 |
| 12:01 ET | 1200 | 55.895 |
| 12:03 ET | 290 | 55.89 |
| 12:08 ET | 100 | 55.98 |
| 12:10 ET | 100 | 56 |
| 12:12 ET | 400 | 56.02 |
| 12:14 ET | 200 | 56.04 |
| 12:15 ET | 300 | 55.94 |
| 12:17 ET | 200 | 56.015 |
| 12:19 ET | 1000 | 56.015 |
| 12:21 ET | 200 | 56.1 |
| 12:24 ET | 200 | 56.1 |
| 12:26 ET | 400 | 56.1 |
| 12:28 ET | 400 | 56.3 |
| 12:30 ET | 600 | 56.315 |
| 12:32 ET | 400 | 56.34 |
| 12:33 ET | 300 | 56.335 |
| 12:35 ET | 100 | 56.35 |
| 12:37 ET | 200 | 56.345 |
| 12:39 ET | 600 | 56.44 |
| 12:44 ET | 400 | 56.515 |
| 12:46 ET | 100 | 56.61 |
| 12:48 ET | 900 | 56.43 |
| 12:51 ET | 1691 | 56.47 |
| 12:53 ET | 1220 | 56.4 |
| 01:00 ET | 400 | 56.4 |
| 01:02 ET | 400 | 56.46 |
| 01:04 ET | 300 | 56.46 |
| 01:06 ET | 600 | 56.61 |
| 01:08 ET | 1244 | 56.59 |
| 01:09 ET | 100 | 56.595 |
| 01:11 ET | 300 | 56.575 |
| 01:13 ET | 1000 | 56.47 |
| 01:20 ET | 600 | 56.445 |
| 01:24 ET | 137 | 56.42 |
| 01:26 ET | 200 | 56.45 |
| 01:27 ET | 200 | 56.525 |
| 01:29 ET | 100 | 56.52 |
| 01:31 ET | 200 | 56.48 |
| 01:33 ET | 200 | 56.44 |
| 01:38 ET | 300 | 56.49 |
| 01:40 ET | 100 | 56.48 |
| 01:42 ET | 100 | 56.47 |
| 01:44 ET | 1112 | 56.34 |
| 01:47 ET | 993 | 56.43 |
| 01:49 ET | 210 | 56.46 |
| 01:51 ET | 1500 | 56.38 |
| 01:54 ET | 3198 | 56.295 |
| 01:58 ET | 823 | 56.31 |
| 02:00 ET | 862 | 56.48 |
| 02:02 ET | 2002 | 56.54 |
| 02:03 ET | 206 | 56.41 |
| 02:05 ET | 100 | 56.43 |
| 02:07 ET | 1900 | 56.515 |
| 02:09 ET | 300 | 56.59 |
| 02:12 ET | 400 | 56.58 |
| 02:14 ET | 100 | 56.66 |
| 02:16 ET | 914 | 56.53 |
| 02:18 ET | 400 | 56.48 |
| 02:20 ET | 100 | 56.55 |
| 02:21 ET | 900 | 56.625 |
| 02:23 ET | 400 | 56.67 |
| 02:25 ET | 200 | 56.72 |
| 02:27 ET | 704 | 56.715 |
| 02:30 ET | 100 | 56.715 |
| 02:32 ET | 431 | 56.79 |
| 02:34 ET | 200 | 56.81 |
| 02:36 ET | 600 | 56.775 |
| 02:39 ET | 1400 | 56.7 |
| 02:41 ET | 200 | 56.73 |
| 02:43 ET | 500 | 56.665 |
| 02:45 ET | 700 | 56.6 |
| 02:50 ET | 4649 | 56.375 |
| 02:52 ET | 619 | 56.3 |
| 02:54 ET | 300 | 56.38 |
| 02:56 ET | 100 | 56.42 |
| 02:57 ET | 300 | 56.41 |
| 02:59 ET | 200 | 56.41 |
| 03:01 ET | 900 | 56.43 |
| 03:03 ET | 100 | 56.425 |
| 03:06 ET | 7010 | 56.49 |
| 03:08 ET | 200 | 56.48 |
| 03:10 ET | 6772 | 56.41 |
| 03:12 ET | 1160 | 56.33 |
| 03:14 ET | 2400 | 56.12 |
| 03:17 ET | 925 | 56.25 |
| 03:19 ET | 517 | 56.24 |
| 03:21 ET | 200 | 56.23 |
| 03:24 ET | 600 | 56.23 |
| 03:26 ET | 200 | 56.195 |
| 03:28 ET | 1200 | 56.07 |
| 03:30 ET | 100 | 56.07 |
| 03:32 ET | 300 | 56.15 |
| 03:33 ET | 300 | 56.15 |
| 03:35 ET | 688 | 56.22 |
| 03:37 ET | 1700 | 56.08 |
| 03:39 ET | 300 | 56.05 |
| 03:42 ET | 699 | 56.055 |
| 03:44 ET | 900 | 56.01 |
| 03:46 ET | 2100 | 55.92 |
| 03:48 ET | 894 | 55.99 |
| 03:50 ET | 13257 | 56.185 |
| 03:51 ET | 8322 | 56.26 |
| 03:53 ET | 5269 | 56.36 |
| 03:55 ET | 3397 | 56.505 |
| 03:57 ET | 4947 | 56.43 |
| 04:00 ET | 19795 | 56.55 |
Today
BRIEF-Prothena Reports Topline Early-Stage Trial Results Of Alzheimer’s Disease Treatment, from 4 hours ago by Thomson Reuters
4 hours ago by Thomson ReutersProthena Delivers 'Positive' Results From Phase 1 Study of Single-Dose Treatment for Alzheimer's Disease, from 4 hours ago by MT Newswires
4 hours ago by MT NewswiresProthena Reports Topline Phase 1 Single Ascending Dose Study Results of PRX005, a Novel Anti-MTBR-Tau Antibody for the Potential Treatment of Alzheimer's Disease, from 6 hours ago by Business Wire
6 hours ago by Business Wire
Jan 27, 2023
Piper Sandler Starts Prothena at Overweight With $94 Price Target, from 10:08AM ET on Friday Jan 27, 2023 by MT Newswires
10:08AM ET on Friday Jan 27, 2023 by MT Newswires
Jan 13, 2023
--RBC Lifts Price Target on Prothena to $56 From $55, Maintains Sector Perform Rating, from 8:03AM ET on Friday Jan 13, 2023 by MT Newswires
8:03AM ET on Friday Jan 13, 2023 by MT Newswires
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Prothena Corporation PLC | 2.8B | -16.9x | --- |
Insmed Inc | 2.8B | -5.9x | --- |
Blueprint Medicines Corp | 2.8B | -3.9x | --- |
Myovant Sciences Ltd | 2.6B | -14.0x | --- |
Ginkgo Bioworks Holdings Inc | 2.8B | -0.9x | --- |
Revance Therapeutics Inc | 2.7B | -8.9x | --- |
Company Information
Prothena Corporation Public Limited Company is a late-stage clinical company engaged in the protein dysregulation and a pipeline of investigational therapies for rare peripheral amyloid and neurodegenerative diseases. The Company is advancing a pipeline of therapeutic candidates for a range of indications and targets to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins. The Company is also advancing several discovery and preclinical-stage programs for neurological diseases with unmet medical needs such as AD and amyotrophic lateral sclerosis (ALS). The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Birtamimab for the treatment of amyloid light-chain (AL) amyloidosis. The Company's pipeline includes AL Amyloidosis & Birtamimab, Parkinson’s Disease & Prasinezumab, Transthyretin amyloidosis (ATTR) & PRX004, Alzheimer’s Disease and Pioneering Neuroscience.
Contact Information
- Headquarters
- 77 Sir John Rogersons Quay Block C, Grand Canal DocklandsDUBLIN, Ireland D02 T804
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Lars Ekman
- President, Chief Executive Officer, Director
- Gene Kinney
- Chief Financial Officer, Chief Strategy Officer
- Tran Nguyen
- Chief Operating Officer
- Brandon Smith
- Chief Accounting Officer
- Karin Walker
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.8B |
|---|---|
Revenue (TTM) | $5.2M |
Shares Outstanding | 51.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $-3.34 |
Book Value | $9.99 |
P/E Ratio | -16.9x |
Price/Sales (TTM) | 545.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,193.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
